| |
|
Form Serial Number: |
CS20190409E00263 |
| 1.
Date of relevant event: |
04/04/2019
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
04/04/2019
(dd/mm/yyyy)
|
| 3.
Stock code: |
00719 |
| 4.
Name of listed corporation: |
山东新华制药股份有限公司 - H股 |
| 5.
Class of shares: |
A Shares |
| 6.
Number of issued shares in class: |
426,859,447 |
| 7.
Name of substantial shareholder: |
华鲁控股集团有限公司 |
| 8.
Registered office: |
山东省济南市历下区舜海路219号华创观礼中心A座22楼 |
| 9.
Principal place of business in Hong Kong: |
香港湾仔港湾道一号会展广场办公大楼42楼 |
| 15.
Exchange on which listed: |
|
| 16.
Name of listed parent and exchange on which parent is listed: |
|
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1013 | You first acquire a notifiable interest because:
any other event (you must briefly describe the relevant event in the Supplementary Information box) |
|
| 2201 | Interest of corporation controlled by you |
|
|
204,864,092 |
CNY |
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 0 | 0.00 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 204,864,092 | 32.94 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| 华鲁集团有限公司 | 香港湾仔港湾道一号会展广场办公大楼42楼 | 华鲁控股集团有限公司 | 100.00 | N | |
| 维斌有限公司 | 香港湾仔港湾道一号会展广场办公大楼42楼 | 华鲁集团有限公司 | 100.00 | Y | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
2018年11月26日，华鲁控股集团有限公司与山东新华医药集团有限责任公司签署《合并协议），约定由华鲁控股集团有限公司吸收合并山东新华医药集团有限责任公司，合并完成后山东新华医药集团有限责任公司注销，山东新华医药集团有限责任公司持有的山东新华制药股份有限公司204,864,092股已发行A股股份自然承继至华鲁控股集团有限公司。2019年4月4日，中国证券登记结算有限责任公司深圳分公司出具《证券过户登记确认书》(业务单号：443000002804)，上述股份过户登记至华鲁控股集团有限公司，华鲁控股集团有限公司成为山东新华制药股份有限公司的控股股东，最终控制人不变，仍然是山东省国资委。
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
09/04/2019
(dd/mm/yyyy)
|
|
|
|
|